Hindalco’s Target Price Revised After Q4 Results; Systematix Maintain ‘Hold’ Rating — Check Upside

Systematix has revised its FY27/FY28 Ebitda estimates on Hindalco upward by 14%/7%, primarily driven by improved assumptions for aluminium downstream margins, higher commodity price assumptions, and a gradual recovery in Novelis margins and shipments.